MedTrace Logo

Effect of Assisted Exercise on Musculoskeletal System and Growth in Preterm Infants

NCT03354988 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-05-11

No results posted yet for this study

Summary

The primary aim of this study is to assess whether physical activity programs in preterm infants improve bone mineralization as well as growth and reduce the risk of fractures.

The secondary aim is to include other potential benefits in terms of length of hospital stay, weaning from mechanical ventilation, feeding tolerance and adverse events

Conditions

  • Osteopenia Prematurity

Interventions

OTHER

Physical exercise group

For the exercise group, systematic physical activity programs consisting of range-of-motion exercises with gentle compression, extension and flexion of all joints of both bilateral upper extremities; including the shoulder, elbow, and wrist and lower extremities; including the hip, knee and ankle, with a total of 12 joints. Each activity was about 10 min a day and was carried out 5 times per week for 4 weeks. This program was started after 1 week of birth. Physical activity continued until discharge from hospital

OTHER

Control group

Other routine care activities such as bathing (every day) and kangaroo care (30 minutes/day), will be done for both the control

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • rania elfarrash, assprofessor · Ain Shams univeristy

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-06-30
Completion
2018-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03354988 on ClinicalTrials.gov